0001209191-23-024390.txt : 20230417 0001209191-23-024390.hdr.sgml : 20230417 20230417060007 ACCESSION NUMBER: 0001209191-23-024390 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230413 FILED AS OF DATE: 20230417 DATE AS OF CHANGE: 20230417 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BREITMEYER JAMES B CENTRAL INDEX KEY: 0001244823 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50549 FILM NUMBER: 23822714 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc. CENTRAL INDEX KEY: 0001260990 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 621715807 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 434-1113 MAIL ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: GTX INC /DE/ DATE OF NAME CHANGE: 20030822 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-04-13 0 0001260990 Oncternal Therapeutics, Inc. ONCT 0001244823 BREITMEYER JAMES B 12230 EL CAMINO REAL, SUITE 230 SAN DIEGO CA 92130 1 1 0 0 Chief Executive Officer 0 Common Stock 2023-04-13 4 P 0 100000 0.29 A 146544 I By Family Trust Common Stock 2023-04-14 4 P 0 47750 0.299 A 194294 I By Family Trust Common Stock 2023-04-14 4 P 0 2250 0.29 A 196544 I By Family Trust Common Stock 541981 D Common Stock 23918 I By Spouse Common Stock 733 I By Child /s/Chase C. Leavitt, Attorney-in-fact 2023-04-17